On ECHEMI
Home > Drugs > Beijing SL Pharmaceutical Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd.
  • Founded in:

    1994-12-24
  • Country:

    China China
  • Address:

    4th Floor, Building 1, Bitongyuan, No. 69, Fushi Road, Haidian District, Beijing
  • Tax NO.:

    91110000102299779W
  • Registered Funds:

    1,027.35 million yuan
  • Website:

  • Email:

Related Drugs
Cytidine Triphosphate Disodium Injection
The main ingredients and chemical names of this product are: Cytidine triphosphate disodium. Cytosine nucleoside-5-triphosphate disodium. Molecular formula: C9H14N3Na2O14P3. Molecular weight: 527.14.
Name Description Content CAS NO. Registered Holders
Cytidine 5'-triphosphate disodium salt

Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.

More

Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.

36051-68-0 10
Cytidine Triphosphate Disodium Injection
The main ingredients and chemical names of this product are: Cytidine triphosphate disodium. Cytosine nucleoside-5-triphosphate disodium. Molecular formula: C9H14N3Na2O14P3. Molecular weight: 527.14.
Name Description Content CAS NO. Registered Holders
Cytidine 5'-triphosphate disodium salt

Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.

More

Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.

36051-68-0 10
Recombinant human granulocyte-stimulating factor injection
Recombinant human granulocyte colony-stimulating factor.
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of granulocyte terminal undifferentiated cells.

More

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of granulocyte terminal undifferentiated cells.

0
Recombinant human granulocyte-stimulating factor injection
Main ingredients: recombinant human granulocyte colony stimulating factor.
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Naftopidil Tablets
The main ingredient is naftopidil.
Name Description Content CAS NO. Registered Holders
Naftopidil dihydrochloride

Naftopidil is a selective alpha 1 receptor antagonist that can inhibit the increase in blood pressure caused by alpha 1 receptors. It has a hypotensive effect on a variety of hypertensive animal models, with a long duration of hypotensive effect, and does not cause reflex tachycardia during hypotensive treatment. No obvious first-dose effect or drug resistance was observed after multiple oral administrations. It can reduce the total peripheral resistance of anesthetized open-chest dogs, dilate peripheral blood vessels, and has no significant effect on cardiac output. It can also relieve the sympathetic tension of the prostate and urethra caused by the excitement of the receptor through the alpha 1 receptor blocking effect, reduce the intraurethral pressure, and improve the symptoms of urination disorders caused by benign prostatic hyperplasia.

More

Naftopidil is a selective alpha 1 receptor antagonist that can inhibit the increase in blood pressure caused by alpha 1 receptors. It has a hypotensive effect on a variety of hypertensive animal models, with a long duration of hypotensive effect, and does not cause reflex tachycardia during hypotensive treatment. No obvious first-dose effect or drug resistance was observed after multiple oral administrations. It can reduce the total peripheral resistance of anesthetized open-chest dogs, dilate peripheral blood vessels, and has no significant effect on cardiac output. It can also relieve the sympathetic tension of the prostate and urethra caused by the excitement of the receptor through the alpha 1 receptor blocking effect, reduce the intraurethral pressure, and improve the symptoms of urination disorders caused by benign prostatic hyperplasia.

57149-07-2 13
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.